Rosa and Co LLC Company Profile
Rosa helps clients with their critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of R&D related challenges, Rosa offers customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these capabilities, Rosa’s clients participate in customized model creation, testing, and research simulations, retain the models, and acquire the ability to perform model research to inform decisions and better understand implications for their drug development programs. Rosa’s staff has unparalleled professional experience in applying modeling and simulation to accelerate drug development and have completed hundreds of engagements with clients in virtually all therapeutic areas. The Rosa team is unique in its breadth and depth of disease area experience, including metabolic diseases, oncology, inflammation, immune dysfunction, CNS, dermatology, and antibacterial/antiviral biology. For more information, visit www.rosaandco.com.
News from Rebecca Baillie:
Rosa & Co. CEO to Speak on Systems Pharmacology and Scientific Innovation
SAN CARLOS, Calif., Feb. 11, 2014 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation research, today announced that Dr. Ron D. Beaver, Ph.D., CEO will present a webinar entitled "Systems Pharmacology: Science or Non-Science? And so what?" in Rosa's "Impact of Modeling & Simulation in […]
Rosa & Co. Announces the Appointment of Ananth Kadambi, PhD as Sr. Vice President, PhysioPD™
SAN CARLOS, Calif., Feb. 5, 2014 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Ananth Kadambi, PhD, as Senior Vice President, PhysioPD, to manage their rapidly-expanding business in Japan and Asia. (Logo: http://photos.prnewswire.com/prnh/20140205/PH59278LOGO) "We are pleased to add Dr. Kadambi to […]
Rosa & Co. LLC Expands in Systems Pharmacology Market with Acquisition of Entelos Service Business
SAN CARLOS, Calif., Jan. 23, 2014 /PRNewswire/ — Rosa & Co. LLC (www.rosaandco.com) today announced the acquisition of the consulting service business of Entelos Holdings, Inc. (www.entelos.com), which conducts mechanistic, physiologic, in silico modeling projects for customers for the purpose of pharmaceutical research and development. The acquisition, which closed January 7, 2014, further extends Rosa's […]
The KressWorks Foundation and Rosa Partner to Develop a Ewing's Sarcoma PhysioPD™ Research Platform
SAN CARLOS, Calif., Dec. 9, 2013 /PRNewswire/ — Rosa & Co. LLC is pleased to announce it has established an alliance with the KressWorks Foundation to develop a Ewing's Sarcoma PhysioPD Research Platform, a quantitative model of the physiologic and pharmacologic mechanisms involved in Ewing's Sarcoma. The Platform will be used to advance the development […]
Pharmaceutical Modeling Experts Rosa & Co. Expand Operations, Hire New Principal Scientist
Katherine Kudrycki, Ph.D. contributes more than 20 years of scientific expertise in dermatological science, inflammation, signal transduction, and gene expression research SAN CARLOS, Calif., Nov. 13, 2013 /PRNewswire/ — Dr. Kudrycki brings over 20 years of scientific expertise in dermatological science, inflammation, signal transduction, and gene expression research. In addition, she has extensive experience applying mathematical […]
Drug Development Advisory Firm Rosa & Co. LLC to Present Two Mechanistic Modeling Presentations at the 28th JSSX Conference
Drs. Reed and Friedrich to discuss application of the Model Qualification Method on October 10 in Tokyo SAN CARLOS, Calif., Oct. 4, 2013 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that Dr. Mike Reed, Chief Scientist, and Dr. Christina Friedrich, Chief Engineer, will […]
